Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHE/300653 stock hub

SHE/300653 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300653is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.3B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300653

In the news

Latest news · SHE/300653

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E36.1

P25 17.1P50 24.2P75 37.8

Trailing P/E47.2

P25 23.5P50 41.3P75 83.2

ROE7.8

P25 -0.9P50 4.1P75 8.8

ROIC22

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300653 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

229

Groups with data

Currency

CNY

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	379
Employees Change	4%
Employees Change Percent	1.07
Enterprise value	CNY 2.6B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE100002NZ1
Last refreshed	2026-05-10
Market cap	CNY 3.3B
Price	CNY 18.42
Price currency	CNY
Rev Per Employee	917,549.9x
Sector	Healthcare
Sic	2836
Symbol	she/300653
Website	https://www.zhbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.16%
EV Earnings	37.16x
EV/EBIT	44.86x
EV/EBITDA	32.49x
EV/FCF	46.09x
EV/Sales	7.54x
FCF yield	1.74%
Forward P/E	36.12x
P/B ratio	3.62x
P/E ratio	47.23x
P/S ratio	9.41x
PE Ratio10 Y	46.14x
PE Ratio3 Y	33.47x
PE Ratio5 Y	39.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	16.8%
EBITDA Margin	23.2%
FCF margin	16.35%
Gross margin	86.5%
Gross Profit	CNY 300.8M
Gross Profit Growth	-5.69%
Gross Profit Growth Q	-15.09%
Gross Profit Growth3 Y	-7.2%
Gross Profit Growth5 Y	-1.3%
Net Income	CNY 70.5M
Net Income Growth	-41.65%
Net Income Growth Q	-44.61%
Net Income Growth Years	0%
Net Income Growth3 Y	-27.33%
Net Income Growth5 Y	-13.17%
Pretax Margin	21.3%
Profit Margin	20.28%
Profit Per Employee	CNY 186,102
Profitable Years	14
ROA	3.63
Roa5y	9.75
ROCE	6.39
ROE	7.75
Roe5y	18.2
ROIC	22
Roic5y	55.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-4.73%
Cagr3y	-24.13%
Cagr5y	-12%
Div CAGR3	-19.45%
Div CAGR5	-1.65%
EPS Growth	-42.58
EPS Growth Q	-46.67
EPS Growth Years	0
EPS Growth3 Y	-32.49
EPS Growth5 Y	-13.41
FCF Growth	-59.19%
FCF Growth Q	-84.81%
FCF Growth3 Y	-23.62%
FCF Growth5 Y	8.55%
OCF Growth	-53.86%
OCF Growth Q	-67.19%
OCF Growth10 Y	4.5%
OCF Growth3 Y	-25.91%
OCF Growth5 Y	-13.05%
Revenue Growth	-6.27x
Revenue Growth Q	-16.82x
Revenue Growth Years	1x
Revenue Growth3 Y	-6.44x
Revenue Growth5 Y	-0.16x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.35
Assets	CNY 1B
Cash	CNY 651M
Current Assets	CNY 749.5M
Current Liabilities	CNY 89M
Equity	CNY 904.2M
Interest Coverage	6,647.9
Liabilities	CNY 98.7M
Long Term Assets	CNY 253.4M
Long Term Liabilities	CNY 9.6M
Net Cash	CNY 651M
Net Cash By Market Cap	CNY 19.9
Net Cash Growth	-1.51%
Net Debt EBITDA	CNY -8.07
Net Debt Equity	CNY -0.72
Net Debt FCF	CNY -11.45
Tangible Book Value	CNY 874.9M
Tangible Book Value Per Share	CNY 4.93
WACC	5.3

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.42
Inventory Turnover	1.57
Net Working Capital	CNY 9.5M
Quick ratio	8.02
Working Capital	CNY 660.5M
Working Capital Turnover	CNY 0.53

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.6%
Dividend Growth	-42.63%
Dividend Growth Years	0%
Dividend per share	CNY 0.28
Dividend Years	8
Dividend Yield	1.52%
Ex Div Date	2025-05-27
Last Dividend	CNY 0.46
Payout Frequency	Annual
Payout Ratio	115.85%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-4.73%
200-day SMA	20.65
3Y total return	-56.33%
50-day SMA	19.53
50-day SMA vs 200-day SMA	50under200
5Y total return	-47.22%
All Time High	58.83
All Time High Change	-68.69%
All Time High Date	2022-10-10
All Time Low	6.88
All Time Low Change	167.89%
All Time Low Date	2017-05-16
ATR	0.51
Beta	0.19
Beta1y	0.45
Beta2y	0.55
Ch YTD	-7.76
High	18.57
High52	23.95
High52 Date	2025-08-12
High52ch	-23.09%
Low	18.2
Low52	18.01
Low52 Date	2026-03-23
Low52ch	2.28%
Ma50ch	-5.68%
Price vs 200-day SMA	-10.79%
RSI	40.85
RSI Monthly	39.44
RSI Weekly	37.22
Sharpe ratio	-0.17x
Sortino ratio	-0.03
Total Return	-0.08%
Tr YTD	-7.76
Tr1m	-6.35%
Tr1w	1.15%
Tr3m	-11.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 58.4M
Operating Income Growth	-48.03
Operating Income Growth Q	-50.75
Operating Income Growth3 Y	-32.42
Operating Income Growth5 Y	-16.82
Operating margin	16.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	100,523,276%
Shares Insiders	41.29%
Shares Institutions	4.08%
Shares Out	177,639,950
Shares Qo Q	8.38%
Shares Yo Y	1.6%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 56.9M
Average Volume	2,060,858.1x
Bv Per Share	5.09
CAPEX	CNY -14.2M
Ch1m	-6.35
Ch1w	1.15
Ch1y	-6.92
Ch3m	-11.36
Ch3y	-59.5
Ch5y	-51.93
Ch6m	-8.49
Change	1.1%
Change From Open	0.55
Close	18.22
Days Gap	0.55
Depreciation Amortization	22,237,381
Dollar Volume	34,343,169
Earnings Date	2026-08-04
EBIT	CNY 58.4M
EBITDA	CNY 80.7M
EPS	CNY 0.39
F Score	5
FCF	CNY 56.9M
FCF EV Yield	2.17x
FCF Per Share	CNY 0.32
Financing CF	-81,714,377
Fiscal Year End	December
Founded	2,003
Graham Number	6.68307
Graham Upside	-63.72
Income Tax	CNY 3.6M
Investing CF	-19,540
Is Primary Listing	1
Last Earnings Date	2026-03-31
Last Report Date	2026-03-31
Last Split Date	2022-05-19
Last Split Type	Forward
Lynch Fair Value	CNY 1.95
Lynch Upside	-89.41
Ma150	20.33
Ma150ch	-9.39%
Ma20	19.02
Ma20ch	-3.14%
Net CF	-10,712,821
Next Earnings Date	2026-08-04
Open	18.32
P FCF Ratio	57.54
P OCF Ratio	46.07
Payment Date	2025-05-27
Position In Range	59.46
Ppne	211,781,866
Price Date	2026-05-08
Price EBITDA	CNY 40.56
Ptbv Ratio	3.74
Relative Volume	0.92x
Revenue	347,751,411x
Tax By Revenue	1.02x
Tax Rate	4.8%
Tr6m	-8.49%
Volume	1,864,450
Z Score	24.53

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300653 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.5%

$0.28 annual per share

Payout ratio

+115.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-1.7%

0 consecutive years of growth

Total shareholder yield

-0.1%

Next ex-dividend date: 2025-05-27

Performance

SHE/300653 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300653?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.1%

Share of float held by funds and institutions

Insider ownership

+41.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.6%

Negative means the company is buying back shares.

Technical

SHE/300653 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.8

Neutral momentum band

Price vs 200-day MA

-10.8%

50/200-day relationship not available

Beta (5Y)

0.19

Less volatile than the market

Sharpe ratio

-0.17

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300653

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300653 stock rating?

she/300653 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300653 analysis?

The full report lives at /stocks/she/300653/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300653?

The latest report frames she/300653 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300653 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.